COVID-Cancer Rapid Response Award

Funding of €75,000 to €225,000 is available for projects that are patient-focused, seek to take direct action, innovate, and drive immediate improvements in cancer care, services, and outcomes across three priority areas

The Irish Cancer Society and the National Cancer Control Programme are accepting applications to the COVID-Cancer Rapid Response Award.

The aim of this award is to identify evidence-based mitigations for the burdens brought about by COVID on people living with or beyond cancer.

Funding of €75,000 to €225,000 is available for projects that are patient-focused, seek to take direct action, innovate, and drive immediate improvements in cancer care, services, and outcomes across three priority areas:

1. Mitigating the impact of COVID-19 on the psycho-social needs of people affected by cancer (non-palliative).
2. Mitigating the impact of COVID-19 on people with cancer receiving palliative care, those with metastatic/advanced disease, or their family/caregivers.
3. Mitigate the impact of COVID-19 on the general survivorship needs of people affected cancer (other than the palliative and psycho-social needs addressed in priority areas 1 and 2).

The deadline for applications is 11 August 2021 at 3pm. More information can be found on our website: https://www.cancer.ie/cancer-research/researchers-hub/apply-for-funding-open-calls/covid-cancer-rapid-response-award

If you have any questions, please do not hesitate to contact [email protected]